Molecular Devices products to be supplied and serviced by Bio-Strategy
After 1 June, Molecular Devices products (previously supplied by MDS Analytical Technologies) will be supplied, serviced and supported by Bio-Strategy in both Australia and New Zealand.
Most of MDS Analytical Technologies' Australian employees have joined Bio-Strategy, and instrument warranties and ongoing service agreements have also been transferred to Bio-Strategy.
For any concerns or questions regarding this transition, Bio-Strategy can be contacted on:
Free phone: 1800 00 84 53
Email: info@bio-strategy.com
Web: www.bio-strategy.com
Dr Chris Baldwin is new HaemaLogiX CEO and Managing Director
Having commenced in January, Dr Chris Baldwin is clinical stage Australian biotechnology company...
Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO
To lead the commercialisation of Vaxxas's proprietary high‑density microarray patch (HD‑MAP)...
Optics11 Life appoints Jacquelien ten Dam as CEO
Optics11 Life plans to accelerate its commercial growth in key markets while building strategic...
